The Drug Has Been Approved For Treatment Of Influenza And Other Acute Viral Respiratory Infections (Avri) Including Covid-19, Mucocutaneous Herpes, Genital Wart And Subacute Sclerosing Panencephalitis (Sspe) By Dcgi. Themis Medicare
Found this useful? Share it with your team.
